by Simon Johnson | Jan 27, 2023 | Research
People hospitalized with viral infections like the flu are more likely to have disorders that degrade the nervous system, like Alzheimer’s or Parkinson’s, later in life, a new analysis shows. Researchers found 22 links between viruses and common...
by Simon Johnson | Jan 20, 2023 | Research
International Validation of the Modified Erasmus GBS Outcome Score Abstract Background and Objectives The clinical course and outcome of the Guillain-Barré syndrome (GBS) are diverse and vary among regions. The modified Erasmus GBS Outcome Score (mEGOS), developed...
by Simon Johnson | Sep 13, 2022 | Research
Background CIDP – although a rare disease – is the most common chronic autoimmune neuropathy. It is associated with damage of the peripheral nerve myelin, resulting in mostly symmetric sensorimotor symptoms including weakness, numbness, areflexia and...
by Simon Johnson | May 6, 2022 | Research
OBJECTIVE: COVID-19 has been associated with neurological complications such as Guillain-Barre syndrome (GBS). Several cases have been reported, but without functional outcome data after intensive rehabilitation and medium-term follow-up. METHODS: In this...
by Simon Johnson | Feb 28, 2022 | Research
Abstract Vaccination against viruses has rarely been associated with Guillain-Barré syndrome (GBS). An association with the COVID-19 vaccine is unknown. We performed a population-based study of National Health Service data in England and a multicentre surveillance...
by Simon Johnson | Jan 13, 2022 | Research
Falls in people post-Guillain-Barré syndrome in the United Kingdom: A national cross-sectional survey of community based adults Guillain-Barré syndrome (GBS) has several enduring effects that can lead to further harm and/or lower quality of life. These effects include...
